Announcement

Collapse
No announcement yet.

BET 1: Oseltamivir use for quicker alleviation of symptoms, fewer hospital admissions and lower mortality in adult patients with influenza B

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • BET 1: Oseltamivir use for quicker alleviation of symptoms, fewer hospital admissions and lower mortality in adult patients with influenza B

    Emerg Med J. 2019 Jan;36(1):55-56. doi: 10.1136/emermed-2018-208381.1.
    BET 1: Oseltamivir use for quicker alleviation of symptoms, fewer hospital admissions and lower mortality in adult patients with influenza B.

    Bromley C1, Reynard C2.
    Author information

    Abstract

    A short cut review was carried out to establish whether Oseltamivir leads to faster alleviation of symptoms, fewer hospital admissions and lower mortality in adult patients with confirmed influenza B presenting to the Emergency Department. Two studies were directly relevant to the question using the described search methodology on Ovid Medline and Embase. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these papers are tabulated. The clinical bottom line: there is no good evidence that oseltamivir results in quicker alleviation of symptoms, fewer hospital admissions or lower mortality in adult patients with influenza B.
    ? Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.


    KEYWORDS:

    emergency care systems

    PMID: 30635346 DOI: 10.1136/emermed-2018-208381.1
Working...
X